生物
乳腺癌
线粒体DNA
基因
分子生物学
突变
冷PCR
编码区
原发性肿瘤
体细胞
癌症
癌症研究
点突变
遗传学
转移
作者
Paola Parrella,Yan Xiao,Makiko Fliss,Montse Sánchez‐Céspedes,Paola Mazzarelli,Monica Rinaldi,Theresa L. Nicol,Edward W. Gabrielson,Carmela Cuomo,D Cohen,Sunil Pandit,Myla Spencer,Carla Rabitti,Vito Michele Fazio,David Sidransky
出处
期刊:PubMed
[National Institutes of Health]
日期:2001-10-15
卷期号:61 (20): 7623-6
被引量:242
摘要
To determine the frequency and distribution of mitochondrial DNA mutations in breast cancer, 18 primary breast tumors were analyzed by direct sequencing. Twelve somatic mutations not present in matched lymphocytes and normal breast tissues were detected in 11 of the tumors screened (61%). Of these mutations, five (42%) were deletions or insertions in a homopolymeric C-stretch between nucleotides 303-315 (D310) within the D-loop. The remaining seven mutations (58%) were single-base substitutions in the coding (ND1, ND4, ND5, and cytochrome b genes) or noncoding regions (D-loop) of the mitochondrial genome. In three cases (25%), the mutations detected in coding regions led to amino acid substitutions in the protein sequence. We then screened an additional 46 primary breast tumors with a rapid PCR-based assay to identify poly-C alterations in D310, and we found seven more cancers with alterations. Using D310 mutations as clonal marker, we detected identical changes in five of five matched fine-needle aspirates and in four of four metastases-positive lymph nodes. The high frequency of D310 alterations in primary breast cancer combined with the high sensitivity of the PCR-based assays provides a new molecular tool for cancer detection.
科研通智能强力驱动
Strongly Powered by AbleSci AI